Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




High Blood Sugar During Pregnancy Increases Risk of Diabetes

By LabMedica International staff writers
Posted on 02 Oct 2018
Mothers with elevated blood glucose during pregnancy, even if not high enough to meet the traditional definition of gestational diabetes, were significantly more likely to have developed type 2 diabetes a decade after pregnancy than their counterparts without high blood glucose.

In a recent study of children born to mothers with elevated or normal glucose, there was no statistical significant difference between the two groups of children in terms of their combined overweight and obesity, which was the study’s primary outcome. More...
However, when obesity was measured alone, children of mothers with elevated blood glucose were significantly more likely to be obese.

An international team of scientists led by those at the Northwestern University Feinberg School of Medicine (Chicago, IL, USA) examined associations of gestational diabetes (GD) with maternal glucose metabolism and childhood adiposity 10 to 14 years’ postpartum. The follow-up study evaluated the long-term outcomes of 4,697 mothers and 4,832 children; study visits occurred between February 13, 2013, and December 13, 2016. Gestational diabetes was defined post hoc using criteria consisting of one or more of the following 75-g oral glucose tolerance test results (fasting plasma glucose ≥92 mg/dL; 1-hour plasma glucose level ≥180 mg/dL; 2-hour plasma glucose level ≥153 mg/dL).

The scientists reported that the criteria for GD were met by 14.3% (672/4,697) of mothers overall and by 14.1% (683/4,832) of mothers of participating children. Among mothers with GD, 52.2% (346/663) developed a disorder of glucose metabolism versus 20.1% (791/3,946) of mothers without GD (odds ratio [OR], 3.44; risk difference [RD], 25.7%). Among children of mothers with GD, 39.5% (269/681) were overweight or obese and 19.1% (130/681) were obese versus 28.6% (1,172/4,094) and 9.9% (405/4,094), respectively, for children of mothers without GD. Among women with elevated blood glucose during pregnancy, nearly 11% had type 2 diabetes at the follow-up study visit 10 to 14 years after childbirth and about 42% had prediabetes. Of their counterparts who did not have elevated blood glucose during pregnancy, about 2% had type 2 diabetes and about 18% had prediabetes.

The authors concluded that among women with GD identified by contemporary criteria compared with those without it, GD was significantly associated with a higher maternal risk for a disorder of glucose metabolism during long-term follow-up after pregnancy. Barbara Linder, MD, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, Bethesda, MD, USA), said, “The differences in mothers and their children due to the mother’s higher blood glucose are very concerning. Even accounting for the mother’s weight, glucose had an independent effect. Our findings add to the motivation to find ways to help women at high risk for gestational diabetes who are or plan to get pregnant to take steps to reduce their risk.” The study was published on September 11, 2018, in the Journal of the American Medical Association.

Related Links:
Northwestern University Feinberg School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.